Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Change in Cash: 2010-2025

Historic Change in Cash for Sunshine Biopharma (SBFM) over the last 13 years, with Sep 2025 value amounting to -$770,560.

  • Sunshine Biopharma's Change in Cash fell 950.21% to -$770,560 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.4 million, marking a year-over-year increase of 64.57%. This contributed to the annual value of -$5.6 million for FY2024, which is 7.38% up from last year.
  • Per Sunshine Biopharma's latest filing, its Change in Cash stood at -$770,560 for Q3 2025, which was down 141.76% from $1.8 million recorded in Q2 2025.
  • In the past 5 years, Sunshine Biopharma's Change in Cash registered a high of $28.5 million during Q2 2022, and its lowest value of -$19.0 million during Q4 2022.
  • Its 3-year average for Change in Cash is -$1.1 million, with a median of -$770,560 in 2025.
  • As far as peak fluctuations go, Sunshine Biopharma's Change in Cash surged by 41,959.55% in 2022, and later slumped by 25,270.25% in 2024.
  • Quarterly analysis of 5 years shows Sunshine Biopharma's Change in Cash stood at -$335,777 in 2021, then tumbled by 5,547.28% to -$19.0 million in 2022, then spiked by 84.23% to -$3.0 million in 2023, then spiked by 36.95% to -$1.9 million in 2024, then crashed by 950.21% to -$770,560 in 2025.
  • Its Change in Cash was -$770,560 in Q3 2025, compared to $1.8 million in Q2 2025 and -$1.6 million in Q1 2025.